Virus/Host Cell Crosstalk in Hypoxic HPV-Positive Cancer Cells

Worldwide burden of cancer attributable to HPV by site, country and HPV type

(2017) Catherine de Martel et al.   INTERNATIONAL JOURNAL OF CANCER

Induction of dormancy in hypoxic human papillomavirus-positive cancer cells

(2017) Karin Hoppe-Seyler et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cycling hypoxia: A key feature of the tumor microenvironment

(2016) Carine Michiels et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review

(2016) Stergios Boussios et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

RB1: a prototype tumor suppressor and an enigma

(2016) Nicholas J. Dyson   GENES & DEVELOPMENT

Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53

(2016) Denise Martinez-Zapien et al.   NATURE

Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions

(2016) Ouajdi Felfoul et al.   Nature Nanotechnology

Hypoxic control of metastasis

(2016) E. B. Rankin et al.   SCIENCE

Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases

(2016) Joseph G. Skeate et al.   Human Vaccines & Immunotherapeutics

Hypoxia and metabolic adaptation of cancer cells

(2016) K L Eales et al.   Oncogenesis

Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia

(2015) Muhammad Zaeem Noman et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

(2015) Assuntina G. Sacco et al.   JOURNAL OF CLINICAL ONCOLOGY

mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype

(2015) Nicolás Herranz et al.   NATURE CELL BIOLOGY

MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation

(2015) Remi-Martin Laberge et al.   NATURE CELL BIOLOGY

Hypoxia and Predicting Radiation Response

(2015) Richard P. Hill et al.   SEMINARS IN RADIATION ONCOLOGY

Dependence of Intracellular and Exosomal microRNAs on Viral E6/E7 Oncogene Expression in HPV-positive Tumor Cells

(2015) Anja Honegger et al.   PLoS Pathogens

Defining normoxia, physoxia and hypoxia in tumours—implications for treatment response

(2014) S R McKeown   BRITISH JOURNAL OF RADIOLOGY

Geroconversion: irreversible step to cellular senescence

(2014) Mikhail V Blagosklonny   CELL CYCLE

Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment

(2014) Vinit Kumar et al.   IMMUNOLOGY

Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses

(2014) N. J. Roberts et al.   Science Translational Medicine

Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology

(2013) Gregg L. Semenza   Annual Review of Pathology-Mechanisms of Disease

The papillomavirus E7 proteins

(2013) Ann Roman et al.   VIROLOGY

Immunotherapy of HPV-associated head and neck cancer

(2013) Mevyn Nizard et al.   OncoImmunology

Aging, Cellular Senescence, and Cancer

(2012) Judith Campisi   Annual Review of Physiology

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer

(2012) Debbie Saslow et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Hypoxia and gerosuppression: The mTOR saga continues

(2012) Olga V. Leontieva et al.   CELL CYCLE

Cellular senescence and cancer chemotherapy resistance

(2012) Ryan R. Gordon et al.   DRUG RESISTANCE UPDATES

Hypoxia suppresses conversion from proliferative arrest to cellular senescence

(2012) O. V. Leontieva et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Acute versus chronic hypoxia in tumors

(2012) C. Bayer et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Senescence: a new weapon for cancer therapy

(2012) Juan Carlos Acosta et al.   TRENDS IN CELL BIOLOGY

Therapy of Human Papillomavirus-Related Disease

(2012) Peter L. Stern et al.   VACCINE

Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation

(2011) Thomas G. Magaldi et al.   VIROLOGY

Therapy-Induced Senescence in Cancer

(2010) Jonathan A. Ewald et al.   JNCI-Journal of the National Cancer Institute

The Human Papillomavirus Type 16 E6 Oncoprotein Activates mTORC1 Signaling and Increases Protein Synthesis

(2010) J. M. Spangle et al.   JOURNAL OF VIROLOGY

The Search for Infectious Causes of Human Cancers: Where and Why (Nobel Lecture)

(2009) Harald zur Hausen   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5

(2009) Kasper M.A. Rouschop et al.   JOURNAL OF CLINICAL INVESTIGATION

Oncogene Addiction

(2008) I. B. Weinstein et al.   CANCER RESEARCH